Novo Nordisk US
en Español
Home
Diabetes Care
Biopharmaceuticals
About Us
Healthcare Innovations
Alliances
Press
Careers
Contact
Novo Nordisk increased first quarter operating profit by 22%. Gross margin improved by 0.9 percentage points, despite adverse currency development.
